| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 9.782 | 48.954 | 118.011 | 168.307 |
| Total Income - EUR | - | - | - | - | - | - | 9.782 | 48.955 | 118.012 | 168.309 |
| Total Expenses - EUR | - | - | - | - | - | - | 33.169 | 54.758 | 56.808 | 83.985 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -23.387 | -5.803 | 61.204 | 84.323 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -23.485 | -6.266 | 60.051 | 79.997 |
| Employees | - | - | - | - | - | - | 7 | 5 | 5 | 7 |
Check the financial reports for the company - Recrumedica G&D S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 6.536 | 5.916 | 24.211 | 23.282 |
| Current Assets | - | - | - | - | - | - | -20.957 | -9.296 | 61.749 | 69.343 |
| Inventories | - | - | - | - | - | - | 8.764 | 2.183 | 8.190 | 7.481 |
| Receivables | - | - | - | - | - | - | 469 | 557 | 46.792 | 60.016 |
| Cash | - | - | - | - | - | - | -30.190 | -12.036 | 6.766 | 1.845 |
| Shareholders Funds | - | - | - | - | - | - | -23.445 | -29.784 | 30.357 | 80.037 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 9.023 | 26.404 | 55.603 | 12.588 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8710
|
|||||||||
Comments - Recrumedica G&D S.r.l.